Our research encompasses a broad spectrum of skull base tumors, including pituitary adenomas, meningiomas, schwannomas and other skull base tumors.
Through collaborative efforts with clinicians and scientists, both locally and internationally, we strive to translate our findings from bench to bedside, ultimately improving outcomes and quality of life for patients affected by these complex malignancies.
Whether it’s deciphering the role of key signaling pathways, exploring the tumor microenvironment, or developing innovative targeted therapies, our laboratory is at the forefront of molecular neuro-oncology research. Together, we are dedicated to making strides towards a future where skull base tumors are better understood, effectively managed, and, ultimately, conquered.
